Usame Rakip
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Usame Rakip has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Mehmet Gazi Boyaci
Department of Neurosurgery, Afyonkarahisar Health Sciences University, Afyonkarahisar, Turkey
14 shared publications - Adem Aslan
Department of Neurosurgery, Afyonkarahisar Health Sciences University, Afyonkarahisar, Turkey
13 shared publications - Serhat Yıldızhan
Department of Neurosurgery, Afyonkarahisar Health Sciences University, Afyonkarahisar, Turkey
11 shared publications - Ihsan Canbek
Department of Neurosurgery, Afyonkarahisar Health Sciences University, Afyonkarahisar, Turkey
9 shared publications - Serhat Korkmaz
Department of Neurosurgery Afyonkarahisar Health Sciences University Afyonkarahisar Turkey
7 shared publications İhSan Canbek
Department of Neurosurgery, Afyonkarahisar Health Sciences University, Afyonkarahisar, Turkey
4 shared publications
Latest Publications
- Open Access
- 9 November 2026
- Published by Wiley in Orthopaedic Surgery
Recurrence After Primary Lumbar Discectomy: Rate, Reoperation, and Risk Factors in A Single‐Center Cohort Over A 10‐Year Study Period
Objective: Recurrent lumbar disc herniation after primary discectomy is a clinically important complication whose temporal pattern, revision surgical profile, and associated comorbidities remain incompletely characterized in long‐term cohorts. We aimed to define the rate and timing of reoperation‐confirmed recurrence, characterize the revision profile, and examine associated risk factors. Methods: This retrospective cohort study included 432 consecutive patients who underwent primary lumbar discectomy between January 2015 and December 2024, with a median follow‐up of 85 months (interquartile range 50–103). Recurrence was defined as reoperation‐confirmed, same‐level ipsilateral reherniation after an initial pain‐free interval. Follow‐up status and external reoperations were verified through the national electronic health record system up to the study end date (6 March 2026), with no loss to follow‐up. Associations were examined using multivariable logistic regression (with Firth penalization) and Cox proportional hazards modeling. Results: Reoperation‐confirmed recurrence occurred in 28 patients (6.5%); this represents the reoperation‐confirmed recurrence rate rather than the overall incidence of recurrent herniation, since conservatively managed recurrences were not counted. Recurrence was predominantly late, with 68% of events beyond the first postoperative year (median 18.5 months). At reoperation, 21 patients (75%) required instrumented posterolateral fusion for objective segmental instability, with a mean segmental translation of 4.2 ± 1.1 mm and a mean angulation of 12.2° ± 2.1° on dynamic flexion–extension radiographs, both exceeding the predefined instability thresholds. The remaining 7 patients (25%) underwent revision discectomy alone. No second recurrence occurred over a median post‐revision follow‐up of 61.5 months. In the primary logistic model, hypertension was associated with recurrence (adjusted odds ratio [OR] 3.42, 95% confidence interval [CI] 1.04–11.21; p = 0.043), whereas the association of diabetes mellitus was of similar magnitude but did not reach statistical significance (OR 3.17, 95% CI 0.97–10.35; p = 0.056). Diabetes mellitus reached significance only in the secondary Firth penalized and time‐to‐event analyses. Active smoking was not associated with recurrence (OR 0.64; p = 0.321). Given the limited number of events ( n = 28), these findings should be regarded as hypothesis‐generating rather than confirmatory; in particular, the study was not powered to overturn existing evidence linking smoking with recurrence, and the 10‐year survival estimate is exploratory given few patients at risk beyond 5 years. Conclusion: In this 10‐year single‐center cohort, reoperation‐confirmed recurrence occurred in 6.5% of patients and was predominantly late (median 18.5 months), indicating that postoperative surveillance should extend beyond the first year. Three quarters of revisions required instrumented fusion for objective instability. No second recurrence was observed. Hypertension was associated with recurrence in the primary analysis, whereas the association of diabetes mellitus did not reach significance in the primary model and was supported only by secondary analyses. Both comorbidities should be investigated further in adequately powered multicenter studies.
- 9 November 2026
- Published by Wiley in Orthopaedic Surgery
Open AccessRecurrence After Primary Lumbar Discectomy: Rate, Reoperation, and Risk Factors in A Single‐Center Cohort Over A 10‐Year Study Period
Objective: Recurrent lumbar disc herniation after primary discectomy is a clinically important complication whose temporal pattern, revision surgical profile, and associated comorbidities remain incompletely characterized in long‐term cohorts. We aimed to define the rate and timing of reoperation‐confirmed recurrence, characterize the revision profile, and examine associated risk factors. Methods: This retrospective cohort study included 432 consecutive patients who underwent primary lumbar discectomy between January 2015 and December 2024, with a median follow‐up of 85 months (interquartile range 50–103). Recurrence was defined as reoperation‐confirmed, same‐level ipsilateral reherniation after an initial pain‐free interval. Follow‐up status and external reoperations were verified through the national electronic health record system up to the study end date (6 March 2026), with no loss to follow‐up. Associations were examined using multivariable logistic regression (with Firth penalization) and Cox proportional hazards modeling. Results: Reoperation‐confirmed recurrence occurred in 28 patients (6.5%); this represents the reoperation‐confirmed recurrence rate rather than the overall incidence of recurrent herniation, since conservatively managed recurrences were not counted. Recurrence was predominantly late, with 68% of events beyond the first postoperative year (median 18.5 months). At reoperation, 21 patients (75%) required instrumented posterolateral fusion for objective segmental instability, with a mean segmental translation of 4.2 ± 1.1 mm and a mean angulation of 12.2° ± 2.1° on dynamic flexion–extension radiographs, both exceeding the predefined instability thresholds. The remaining 7 patients (25%) underwent revision discectomy alone. No second recurrence occurred over a median post‐revision follow‐up of 61.5 months. In the primary logistic model, hypertension was associated with recurrence (adjusted odds ratio [OR] 3.42, 95% confidence interval [CI] 1.04–11.21; p = 0.043), whereas the association of diabetes mellitus was of similar magnitude but did not reach statistical significance (OR 3.17, 95% CI 0.97–10.35; p = 0.056). Diabetes mellitus reached significance only in the secondary Firth penalized and time‐to‐event analyses. Active smoking was not associated with recurrence (OR 0.64; p = 0.321). Given the limited number of events ( n = 28), these findings should be regarded as hypothesis‐generating rather than confirmatory; in particular, the study was not powered to overturn existing evidence linking smoking with recurrence, and the 10‐year survival estimate is exploratory given few patients at risk beyond 5 years. Conclusion: In this 10‐year single‐center cohort, reoperation‐confirmed recurrence occurred in 6.5% of patients and was predominantly late (median 18.5 months), indicating that postoperative surveillance should extend beyond the first year. Three quarters of revisions required instrumented fusion for objective instability. No second recurrence was observed. Hypertension was associated with recurrence in the primary analysis, whereas the association of diabetes mellitus did not reach significance in the primary model and was supported only by secondary analyses. Both comorbidities should be investigated further in adequately powered multicenter studies.
- Open Access
- 16 October 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (20) , 8053
Volumetric Morphometric Analysis of Posterior Fossa Structures Following Posterior Fossa Decompression with Superficial Durotomy in Chiari I Malformation
Background/Objectives: Posterior fossa decompression (PFD) with superficial durotomy is used in Chiari I malformation to limit the CSF-related complications of complete durotomy and duraplasty, but quantitative volumetric evidence has relied on linear measurements, modest cohorts, and heterogeneous methods. We applied a fully automated deep-learning segmentation pipeline to characterize multi-structure volumetric change after PFD with superficial durotomy. Methods: Thirty-three patients (24 females and nine males; mean age, 39.2 ± 13.5 years; two pediatric) with symptomatic Chiari I malformation underwent PFD with superficial durotomy. Pre-operative and 6-month post-operative 3D T1-weighted 1.5T MRIs were segmented using nnU-Net, CERES, TotalSegmentator, and nnDetection. Posterior fossa volume (PFV), supratentorial volume, PFV/STV ratio, cerebellar volume, brainstem volume, fourth ventricle volume, basal cisterns’ CSF volume, and tonsillar descent were computed and compared pre/post using paired t-tests or Wilcoxon tests, Cohen’s d with bootstrapped 95% confidence intervals, and Benjamini–Hochberg correction. The pipeline was developed and validated exclusively on 1.5T Siemens Aera data and is not presented as ready for out-of-box use on other scanner platforms without re-validation. Results: PFV increased from 166.0 ± 12.9 to 172.5 ± 13.1 mL (Δ + 6.5 mL; p < 0.001; d = 1.72). Tonsillar descent decreased from 8.0 ± 2.8 to 4.9 ± 2.8 mm (Δ −3.1 mm; p < 0.001; d = −2.74). Basal cisterns’ CSF volume increased from 8.8 ± 1.5 to 11.0 ± 2.4 mL (Δ + 2.2 mL; p < 0.001; d = 1.16). Fourth ventricle volume increased (p < 0.001; d = 1.58). Cerebellar volume increased modestly (p < 0.001, q < 0.001; d = 0.86), while brainstem volume was unchanged (p = 0.22, q = 0.22; d = −0.11). Seven of eight primary outcomes remained significant after false-discovery-rate correction. Twenty-nine of 33 patients (87.9%) achieved tonsillar ascent of at least 2 mm. Conclusions: Automated volumetric analysis demonstrated significant posterior fossa expansion, basal cisterns’ CSF augmentation, fourth ventricle enlargement, and tonsillar ascent after PFD with superficial durotomy. These effect sizes provide a quantitative benchmark for sample-size estimation in future comparative surgical trials and for patient counseling on expected structural change at 6 months.
- 16 October 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (20) , 8053
Open AccessVolumetric Morphometric Analysis of Posterior Fossa Structures Following Posterior Fossa Decompression with Superficial Durotomy in Chiari I Malformation
Background/Objectives: Posterior fossa decompression (PFD) with superficial durotomy is used in Chiari I malformation to limit the CSF-related complications of complete durotomy and duraplasty, but quantitative volumetric evidence has relied on linear measurements, modest cohorts, and heterogeneous methods. We applied a fully automated deep-learning segmentation pipeline to characterize multi-structure volumetric change after PFD with superficial durotomy. Methods: Thirty-three patients (24 females and nine males; mean age, 39.2 ± 13.5 years; two pediatric) with symptomatic Chiari I malformation underwent PFD with superficial durotomy. Pre-operative and 6-month post-operative 3D T1-weighted 1.5T MRIs were segmented using nnU-Net, CERES, TotalSegmentator, and nnDetection. Posterior fossa volume (PFV), supratentorial volume, PFV/STV ratio, cerebellar volume, brainstem volume, fourth ventricle volume, basal cisterns’ CSF volume, and tonsillar descent were computed and compared pre/post using paired t-tests or Wilcoxon tests, Cohen’s d with bootstrapped 95% confidence intervals, and Benjamini–Hochberg correction. The pipeline was developed and validated exclusively on 1.5T Siemens Aera data and is not presented as ready for out-of-box use on other scanner platforms without re-validation. Results: PFV increased from 166.0 ± 12.9 to 172.5 ± 13.1 mL (Δ + 6.5 mL; p < 0.001; d = 1.72). Tonsillar descent decreased from 8.0 ± 2.8 to 4.9 ± 2.8 mm (Δ −3.1 mm; p < 0.001; d = −2.74). Basal cisterns’ CSF volume increased from 8.8 ± 1.5 to 11.0 ± 2.4 mL (Δ + 2.2 mL; p < 0.001; d = 1.16). Fourth ventricle volume increased (p < 0.001; d = 1.58). Cerebellar volume increased modestly (p < 0.001, q < 0.001; d = 0.86), while brainstem volume was unchanged (p = 0.22, q = 0.22; d = −0.11). Seven of eight primary outcomes remained significant after false-discovery-rate correction. Twenty-nine of 33 patients (87.9%) achieved tonsillar ascent of at least 2 mm. Conclusions: Automated volumetric analysis demonstrated significant posterior fossa expansion, basal cisterns’ CSF augmentation, fourth ventricle enlargement, and tonsillar ascent after PFD with superficial durotomy. These effect sizes provide a quantitative benchmark for sample-size estimation in future comparative surgical trials and for patient counseling on expected structural change at 6 months.
- Open Access
- 25 September 2026
- Published by Springer Nature in BMC Neurology
Long-term outcomes after shunt surgery for normal pressure hydrocephalus: a competing-risks analysis of revision and mortality
Background: Shunt surgery improves symptoms in normal pressure hydrocephalus (NPH), but its long-term morbidity is incompletely characterised because most series report short follow-up and analyse revision risk with methods that ignore the competing risk of death in an elderly, comorbid population. We evaluated the long-term cumulative incidence of revision and mortality using a competing-risks framework. Methods: This retrospective single-centre cohort included 114 consecutive adults who underwent ventriculoperitoneal (VP, n = 80) or lumboperitoneal (LP, n = 34) shunting for NPH between January 2015 and December 2024, with follow-up administratively closed on 31 January 2026 (median follow-up 36 months; maximum 116 months). The cumulative incidence of revision was estimated with the Aalen–Johansen estimator, treating death without revision as a competing event; associations with revision were assessed by cause-specific Cox regression, with aetiology-adjusted and idiopathic-only sensitivity analyses. Shunt-related mortality was adjudicated by a multidisciplinary panel of neurosurgery and neurology specialists against pre-specified criteria. Results: At least one shunt-related complication occurred in 45 patients (39.5%); 42 (36.8%) underwent revision. The cumulative incidence of revision was 19.4% at 12 months, 30.8% at 36 months and 39.4% at 60 months; the conventional Kaplan–Meier method overestimated the cumulative incidence of revision by up to 4% points at five years (43.4% vs. 39.4%). Older age (cause-specific hazard ratio [HR] 1.08 per year, 95% CI 1.03–1.14) and higher Evans index (HR 2.61 per 0.1-unit, 95% CI 1.57–4.34) were independently associated with revision, whereas shunt type was not (VP vs. LP HR 1.01, 95% CI 0.52–1.95; p = 0.98); the shunt-type estimate remained non-significant after adjustment for aetiology and in an idiopathic-only analysis. All-cause mortality was 33.3% (38/114); 7 deaths (6.1%; 18.4% of deaths) were adjudicated as shunt-related, and the remaining 31 were not. Among patients with available paired assessments, iNPHGS scores in the idiopathic subgroup and mRS scores in the overall cohort improved significantly from baseline at all postoperative assessments through two years. Conclusions: The long-term cumulative incidence of revision after shunting for NPH is substantial but, when the competing risk of death is modelled, lower than conventional estimates suggest. Mortality in this elderly cohort is driven predominantly by comorbidity rather than shunt failure, and older age and greater ventricular enlargement—not shunt type—are associated with revision. These findings support the use of competing-risk approaches when estimating long-term revision incidence in NPH cohorts with substantial competing mortality.
- 25 September 2026
- Published by Springer Nature in BMC Neurology
Open AccessLong-term outcomes after shunt surgery for normal pressure hydrocephalus: a competing-risks analysis of revision and mortality
Background: Shunt surgery improves symptoms in normal pressure hydrocephalus (NPH), but its long-term morbidity is incompletely characterised because most series report short follow-up and analyse revision risk with methods that ignore the competing risk of death in an elderly, comorbid population. We evaluated the long-term cumulative incidence of revision and mortality using a competing-risks framework. Methods: This retrospective single-centre cohort included 114 consecutive adults who underwent ventriculoperitoneal (VP, n = 80) or lumboperitoneal (LP, n = 34) shunting for NPH between January 2015 and December 2024, with follow-up administratively closed on 31 January 2026 (median follow-up 36 months; maximum 116 months). The cumulative incidence of revision was estimated with the Aalen–Johansen estimator, treating death without revision as a competing event; associations with revision were assessed by cause-specific Cox regression, with aetiology-adjusted and idiopathic-only sensitivity analyses. Shunt-related mortality was adjudicated by a multidisciplinary panel of neurosurgery and neurology specialists against pre-specified criteria. Results: At least one shunt-related complication occurred in 45 patients (39.5%); 42 (36.8%) underwent revision. The cumulative incidence of revision was 19.4% at 12 months, 30.8% at 36 months and 39.4% at 60 months; the conventional Kaplan–Meier method overestimated the cumulative incidence of revision by up to 4% points at five years (43.4% vs. 39.4%). Older age (cause-specific hazard ratio [HR] 1.08 per year, 95% CI 1.03–1.14) and higher Evans index (HR 2.61 per 0.1-unit, 95% CI 1.57–4.34) were independently associated with revision, whereas shunt type was not (VP vs. LP HR 1.01, 95% CI 0.52–1.95; p = 0.98); the shunt-type estimate remained non-significant after adjustment for aetiology and in an idiopathic-only analysis. All-cause mortality was 33.3% (38/114); 7 deaths (6.1%; 18.4% of deaths) were adjudicated as shunt-related, and the remaining 31 were not. Among patients with available paired assessments, iNPHGS scores in the idiopathic subgroup and mRS scores in the overall cohort improved significantly from baseline at all postoperative assessments through two years. Conclusions: The long-term cumulative incidence of revision after shunting for NPH is substantial but, when the competing risk of death is modelled, lower than conventional estimates suggest. Mortality in this elderly cohort is driven predominantly by comorbidity rather than shunt failure, and older age and greater ventricular enlargement—not shunt type—are associated with revision. These findings support the use of competing-risk approaches when estimating long-term revision incidence in NPH cohorts with substantial competing mortality.
- Open Access
- 15 September 2026
- Published by Elsevier in American Journal of Otolaryngology
- Vol. 47 (6)
Multilayer free-graft reconstruction with platelet-rich plasma augmentation for nasoseptal flap-sparing in endoscopic transsphenoidal surgery: A single-center prospective feasibility study
- 15 September 2026
- Published by Elsevier in American Journal of Otolaryngology
- Vol. 47 (6)
Open AccessMultilayer free-graft reconstruction with platelet-rich plasma augmentation for nasoseptal flap-sparing in endoscopic transsphenoidal surgery: A single-center prospective feasibility study
- 12 August 2026
- Published by Springer Nature in European Journal of Trauma and Emergency Surgery
- Vol. 52 (1) , 243
Surgical timing and mortality in acute traumatic subdural hematoma: is the four-hour threshold confounded by injury severity?
- 12 August 2026
- Published by Springer Nature in European Journal of Trauma and Emergency Surgery
- Vol. 52 (1) , 243
Surgical timing and mortality in acute traumatic subdural hematoma: is the four-hour threshold confounded by injury severity?
- Open Access
- 2 August 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (15) , 6016
Baseline Neurological Severity and Early Imaging Findings Predict 3-Month Functional Outcome in Anterior-Circulation Acute Ischemic Stroke: A Retrospective Cohort Study with One-Year Follow-Up
Background: Bedside prognostication after acute ischemic stroke remains challenging despite the availability of several composite scores, which often demand variables not routinely obtained at admission. Whether the combination of baseline neurological severity and early non-contrast computed tomography findings can support parsimonious, contemporaneous prediction of 3-month functional outcome is an open question, particularly given the well-documented overlap between clinical and imaging measures of stroke extent. Methods: We retrospectively analyzed 432 consecutive adults admitted with confirmed anterior-circulation acute ischemic stroke to a Turkish tertiary care university hospital between January 2022 and December 2025. The primary outcome was a poor functional outcome, defined as modified Rankin Scale (mRS) score 3–6 at 3 months. A prespecified multivariable logistic regression model incorporated three admission variables: baseline National Institutes of Health Stroke Scale (NIHSS) per five-point increment, Alberta Stroke Program Early CT Score (ASPECTS) per one-point increment, and age dichotomized at 65 years. Model performance was assessed with the area under the receiver operating characteristic curve (AUC), five-fold stratified cross-validation, and calibration testing. We additionally performed DeLong tests, net reclassification improvement (NRI), and integrated discrimination improvement (IDI) analyses to evaluate the incremental contribution of ASPECTS, and compared the parsimonious model against a comprehensive multivariable model containing ten predictors. Results: At 3 months, 252 patients (58.3%) had poor functional outcome, with 177 deaths (41.0%). Baseline NIHSS emerged as the dominant predictor (adjusted odds ratio [aOR] 4.16 per five-point increase, 95% confidence interval [CI] 2.79–6.22, p < 0.001), whereas ASPECTS retained no independent prognostic value after adjustment (aOR 0.99 per point, 95% CI 0.73–1.34, p = 0.952). Age ≥ 65 years was likewise non-significant (aOR 0.79, 95% CI 0.46–1.37, p = 0.405). The parsimonious model achieved excellent discrimination (AUC 0.904, 95% CI 0.876–0.932; cross-validated AUC 0.899, 95% CI 0.873–0.926) and good overall calibration on internal validation (calibration slope 0.958; calibration-in-the-large 0.009), although the Hosmer–Lemeshow test was significant (p = 0.001), reflecting localized miscalibration in the intermediate-risk range. Adding ASPECTS to a reduced model containing only NIHSS and age produced no meaningful discrimination gain (ΔAUC + 0.0003, DeLong p = 0.50; IDI ≈ 0), consistent with substantial variance sharing between NIHSS and ASPECTS (Spearman ρ = −0.89). A comprehensive model including infarct volume, Glasgow Coma Scale, reperfusion therapy, and comorbidities did not improve discrimination (AUC 0.905) and yielded a worse Akaike information criterion, supporting the sufficiency of the parsimonious model. Conclusions: In this Turkish tertiary center cohort, baseline NIHSS captured most of the prognostic information available at admission, and early ASPECTS added minimal independent value once neurological severity was accounted for. Findings should be interpreted in the context of the high case-mix severity of this referral population; external validation in independent, multicenter cohorts is required before clinical implementation is considered.
- 2 August 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (15) , 6016
Open AccessBaseline Neurological Severity and Early Imaging Findings Predict 3-Month Functional Outcome in Anterior-Circulation Acute Ischemic Stroke: A Retrospective Cohort Study with One-Year Follow-Up
Background: Bedside prognostication after acute ischemic stroke remains challenging despite the availability of several composite scores, which often demand variables not routinely obtained at admission. Whether the combination of baseline neurological severity and early non-contrast computed tomography findings can support parsimonious, contemporaneous prediction of 3-month functional outcome is an open question, particularly given the well-documented overlap between clinical and imaging measures of stroke extent. Methods: We retrospectively analyzed 432 consecutive adults admitted with confirmed anterior-circulation acute ischemic stroke to a Turkish tertiary care university hospital between January 2022 and December 2025. The primary outcome was a poor functional outcome, defined as modified Rankin Scale (mRS) score 3–6 at 3 months. A prespecified multivariable logistic regression model incorporated three admission variables: baseline National Institutes of Health Stroke Scale (NIHSS) per five-point increment, Alberta Stroke Program Early CT Score (ASPECTS) per one-point increment, and age dichotomized at 65 years. Model performance was assessed with the area under the receiver operating characteristic curve (AUC), five-fold stratified cross-validation, and calibration testing. We additionally performed DeLong tests, net reclassification improvement (NRI), and integrated discrimination improvement (IDI) analyses to evaluate the incremental contribution of ASPECTS, and compared the parsimonious model against a comprehensive multivariable model containing ten predictors. Results: At 3 months, 252 patients (58.3%) had poor functional outcome, with 177 deaths (41.0%). Baseline NIHSS emerged as the dominant predictor (adjusted odds ratio [aOR] 4.16 per five-point increase, 95% confidence interval [CI] 2.79–6.22, p < 0.001), whereas ASPECTS retained no independent prognostic value after adjustment (aOR 0.99 per point, 95% CI 0.73–1.34, p = 0.952). Age ≥ 65 years was likewise non-significant (aOR 0.79, 95% CI 0.46–1.37, p = 0.405). The parsimonious model achieved excellent discrimination (AUC 0.904, 95% CI 0.876–0.932; cross-validated AUC 0.899, 95% CI 0.873–0.926) and good overall calibration on internal validation (calibration slope 0.958; calibration-in-the-large 0.009), although the Hosmer–Lemeshow test was significant (p = 0.001), reflecting localized miscalibration in the intermediate-risk range. Adding ASPECTS to a reduced model containing only NIHSS and age produced no meaningful discrimination gain (ΔAUC + 0.0003, DeLong p = 0.50; IDI ≈ 0), consistent with substantial variance sharing between NIHSS and ASPECTS (Spearman ρ = −0.89). A comprehensive model including infarct volume, Glasgow Coma Scale, reperfusion therapy, and comorbidities did not improve discrimination (AUC 0.905) and yielded a worse Akaike information criterion, supporting the sufficiency of the parsimonious model. Conclusions: In this Turkish tertiary center cohort, baseline NIHSS captured most of the prognostic information available at admission, and early ASPECTS added minimal independent value once neurological severity was accounted for. Findings should be interpreted in the context of the high case-mix severity of this referral population; external validation in independent, multicenter cohorts is required before clinical implementation is considered.
- 20 July 2026
- Published by Springer Nature in Neurosurgical Review
- Vol. 49 (1) , 484
Radiological mass effect and neurological status are associated with mortality after burr-hole drainage for chronic subdural hematoma: a 10-year cohort study
Chronic subdural hematoma (CSDH) is increasingly common in older adults and in patients receiving antithrombotic therapy. Although burr-hole drainage is generally safe and effective, perioperative mortality remains a concern, and reliable preoperative predictors are incompletely defined. We aimed to identify independent preoperative predictors of in-hospital mortality after burr-hole drainage for CSDH, with explicit characterization of causes of death, comorbidity burden, and the discriminative performance of candidate predictors. This single-center retrospective cohort study included 121 consecutive adult patients surgically treated for CSDH between January 2015 and December 2024. Preoperative variables included demographics, Glasgow Coma Scale (GCS) score, hematoma thickness, midline shift (MLS), cerebral edema on CT, antithrombotic use, and a comprehensive set of comorbidities (chronic kidney disease, chronic obstructive pulmonary disease, congestive heart failure, coronary artery disease, atrial fibrillation, diabetes mellitus, dementia, malignancy). Intensive care unit admission and postoperative complications were also recorded. The primary outcome was in-hospital mortality. Causes of death were systematically categorized. Associations were evaluated using Firth penalized logistic regression. Discriminative performance was assessed using receiver operating characteristic (ROC) analysis with bootstrap confidence intervals. A prespecified exploratory interaction analysis between cerebral edema and significant midline shift was performed. In-hospital mortality was 12.4% (15/121). The principal cause of death was cerebral herniation (9/15, 60.0%); extracranial complications (respiratory, septic, cardiac) accounted for 6/15 (40.0%). In the original multivariable Firth model, GCS ≤ 13 (adjusted OR 11.71, 95% CI 2.82–48.61, p < 0.001) and cerebral edema (adjusted OR 8.90, 95% CI 1.93–40.98, p = 0.005) were independently associated with mortality. In an extended model incorporating comorbidities, chronic kidney disease (OR 23.78, p = 0.025) and congestive heart failure (OR 42.39, p = 0.043) emerged as additional independent predictors, while cerebral edema (OR 61.89, p = 0.008) and GCS ≤ 13 (OR 5.80, p = 0.032) retained their associations. Combined model discrimination was excellent (Model 1: AUC 0.920; Model 2 with comorbidities: AUC 0.958). Subgroup analysis demonstrated a marked mortality gradient: 0% in patients with neither cerebral edema nor significant midline shift (n = 59), versus 72.2% in patients with both findings (n = 18). The exploratory interaction term (cerebral edema × midline shift ≥ 5 mm) was directionally consistent with synergy but did not reach statistical significance (OR 39.19, 95% CI 0.26–∞, p = 0.152), reflecting limited statistical power. Preoperative neurological impairment and cerebral edema are independently associated with in-hospital mortality after burr-hole drainage for CSDH. The coexistence of cerebral edema and significant midline shift identifies a clinically recognizable high-risk phenotype that may warrant heightened perioperative attention. Renal and cardiac comorbidities further contribute to mortality risk. These findings are hypothesis-generating and require validation in larger, prospective cohorts before incorporation into clinical risk stratification. Clinical trial number: not applicable.
- 20 July 2026
- Published by Springer Nature in Neurosurgical Review
- Vol. 49 (1) , 484
Radiological mass effect and neurological status are associated with mortality after burr-hole drainage for chronic subdural hematoma: a 10-year cohort study
Chronic subdural hematoma (CSDH) is increasingly common in older adults and in patients receiving antithrombotic therapy. Although burr-hole drainage is generally safe and effective, perioperative mortality remains a concern, and reliable preoperative predictors are incompletely defined. We aimed to identify independent preoperative predictors of in-hospital mortality after burr-hole drainage for CSDH, with explicit characterization of causes of death, comorbidity burden, and the discriminative performance of candidate predictors. This single-center retrospective cohort study included 121 consecutive adult patients surgically treated for CSDH between January 2015 and December 2024. Preoperative variables included demographics, Glasgow Coma Scale (GCS) score, hematoma thickness, midline shift (MLS), cerebral edema on CT, antithrombotic use, and a comprehensive set of comorbidities (chronic kidney disease, chronic obstructive pulmonary disease, congestive heart failure, coronary artery disease, atrial fibrillation, diabetes mellitus, dementia, malignancy). Intensive care unit admission and postoperative complications were also recorded. The primary outcome was in-hospital mortality. Causes of death were systematically categorized. Associations were evaluated using Firth penalized logistic regression. Discriminative performance was assessed using receiver operating characteristic (ROC) analysis with bootstrap confidence intervals. A prespecified exploratory interaction analysis between cerebral edema and significant midline shift was performed. In-hospital mortality was 12.4% (15/121). The principal cause of death was cerebral herniation (9/15, 60.0%); extracranial complications (respiratory, septic, cardiac) accounted for 6/15 (40.0%). In the original multivariable Firth model, GCS ≤ 13 (adjusted OR 11.71, 95% CI 2.82–48.61, p < 0.001) and cerebral edema (adjusted OR 8.90, 95% CI 1.93–40.98, p = 0.005) were independently associated with mortality. In an extended model incorporating comorbidities, chronic kidney disease (OR 23.78, p = 0.025) and congestive heart failure (OR 42.39, p = 0.043) emerged as additional independent predictors, while cerebral edema (OR 61.89, p = 0.008) and GCS ≤ 13 (OR 5.80, p = 0.032) retained their associations. Combined model discrimination was excellent (Model 1: AUC 0.920; Model 2 with comorbidities: AUC 0.958). Subgroup analysis demonstrated a marked mortality gradient: 0% in patients with neither cerebral edema nor significant midline shift (n = 59), versus 72.2% in patients with both findings (n = 18). The exploratory interaction term (cerebral edema × midline shift ≥ 5 mm) was directionally consistent with synergy but did not reach statistical significance (OR 39.19, 95% CI 0.26–∞, p = 0.152), reflecting limited statistical power. Preoperative neurological impairment and cerebral edema are independently associated with in-hospital mortality after burr-hole drainage for CSDH. The coexistence of cerebral edema and significant midline shift identifies a clinically recognizable high-risk phenotype that may warrant heightened perioperative attention. Renal and cardiac comorbidities further contribute to mortality risk. These findings are hypothesis-generating and require validation in larger, prospective cohorts before incorporation into clinical risk stratification. Clinical trial number: not applicable.
- 22 June 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (7)
Independent associations of MGMT promoter methylation and TERT promoter mutation with overall survival in glioblastoma: a single-center retrospective cohort study
Glioblastomas (World Health Organization [WHO] grade 4) are the most lethal primary brain tumors, with a median overall survival (OS) of 12-15 months despite multimodal treatment. MGMT promoter methylation and TERT promoter mutations are key prognostic biomarkers, but their combined utility remains incompletely defined. This study evaluated the prognostic effects of MGMT methylation, TERT mutations, and adjuvant treatment. We retrospectively analyzed 65 patients with gliomas treated between January 2013 and December 2024, with primary analyses restricted to WHO grade 4 tumors (n = 54). MGMT methylation was assessed by methylation-specific PCR and TERT mutations (C228T/C250T) by Sanger sequencing. Survival was analyzed using Kaplan-Meier methods and multivariable Cox regression with bootstrap validation. In the grade 4 cohort, median OS was 12.7 months. MGMT methylation was present in 50.0% and TERT mutations in 68.5%. MGMT methylation independently predicted improved survival (aHR 0.45, 95% CI 0.24-0.87, p = 0.018), while TERT mutation predicted worse survival (aHR 2.93, 95% CI 1.46-5.87, p = 0.003). Adjuvant chemoradiotherapy was associated with improved OS (aHR 0.44, 95% CI 0.24-0.81, p = 0.008). Combined stratification identified four prognostic subgroups, with MGMT-methylated/TERT-wild-type patients showing the longest survival (median OS 19.0 months). The model demonstrated acceptable discrimination (C-index 0.697). MGMT methylation and TERT mutations are independent prognostic markers in glioblastoma. This study provides real-world evidence that both biomarkers retain prognostic value after adjustment for adjuvant treatment within an internally validated model. Combined MGMT/TERT assessment provides clinically meaningful four-tier risk stratification and supports routine prognostic evaluation.
- 22 June 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (7)
Independent associations of MGMT promoter methylation and TERT promoter mutation with overall survival in glioblastoma: a single-center retrospective cohort study
Glioblastomas (World Health Organization [WHO] grade 4) are the most lethal primary brain tumors, with a median overall survival (OS) of 12-15 months despite multimodal treatment. MGMT promoter methylation and TERT promoter mutations are key prognostic biomarkers, but their combined utility remains incompletely defined. This study evaluated the prognostic effects of MGMT methylation, TERT mutations, and adjuvant treatment. We retrospectively analyzed 65 patients with gliomas treated between January 2013 and December 2024, with primary analyses restricted to WHO grade 4 tumors (n = 54). MGMT methylation was assessed by methylation-specific PCR and TERT mutations (C228T/C250T) by Sanger sequencing. Survival was analyzed using Kaplan-Meier methods and multivariable Cox regression with bootstrap validation. In the grade 4 cohort, median OS was 12.7 months. MGMT methylation was present in 50.0% and TERT mutations in 68.5%. MGMT methylation independently predicted improved survival (aHR 0.45, 95% CI 0.24-0.87, p = 0.018), while TERT mutation predicted worse survival (aHR 2.93, 95% CI 1.46-5.87, p = 0.003). Adjuvant chemoradiotherapy was associated with improved OS (aHR 0.44, 95% CI 0.24-0.81, p = 0.008). Combined stratification identified four prognostic subgroups, with MGMT-methylated/TERT-wild-type patients showing the longest survival (median OS 19.0 months). The model demonstrated acceptable discrimination (C-index 0.697). MGMT methylation and TERT mutations are independent prognostic markers in glioblastoma. This study provides real-world evidence that both biomarkers retain prognostic value after adjustment for adjuvant treatment within an internally validated model. Combined MGMT/TERT assessment provides clinically meaningful four-tier risk stratification and supports routine prognostic evaluation.
- Open Access
- 22 June 2026
- Published by Springer Nature in BMC Emergency Medicine
- Vol. 26 (1)
External validation and comparative performance of Marshall, Rotterdam, and Helsinki computed tomography scores in adult traumatic brain injury
Purpose: Computed tomography (CT)-based scoring systems enable standardized quantification of intracranial pathology following traumatic brain injury (TBI). Despite widespread clinical application, external validation studies comparing the Marshall, Rotterdam, and Helsinki CT scores remain limited, particularly in middle-income settings. This study aimed to externally validate these three CT scoring systems and evaluate their incremental prognostic value beyond clinical variables. Methods: This retrospective cohort study included adult patients with traumatic brain injury requiring hospitalization beyond 24 h at a tertiary neurosurgical center between 2022 and 2024. Two neurosurgeons independently scored admission CT scans using the Marshall, Rotterdam, and Helsinki CT scoring systems. The primary outcome was in-hospital mortality, and the secondary outcome was poor functional outcome (Glasgow Outcome Scale 1–3) at hospital discharge. Discriminative performance was assessed using area under the receiver operating characteristic curve (AUC) with DeLong test comparisons. Multivariable logistic regression evaluated incremental prognostic value beyond age and admission Glasgow Coma Scale (GCS). Results: Among 657 patients (mean age 45.9 years, 74.9% male; mild TBI 59.4%, moderate 25.1%, severe 15.5%), in-hospital mortality was 11.0% and poor functional outcome occurred in 23.9%. Among CT-based scores, the Helsinki CT score showed the highest standalone discriminative performance for mortality (AUC 0.793, 95% CI 0.731–0.855), followed by Rotterdam (AUC 0.766, 0.700–0.832) and Marshall (AUC 0.682, 0.625–0.739); Helsinki and Rotterdam both outperformed Marshall. However, when added to a baseline clinical model (age + GCS, AUC 0.876), all CT scores provided minimal to negligible incremental discrimination, with no clinically meaningful improvement in model performance (ΔAUC < 0.005 across all models, all p > 0.20). Similar patterns were observed for poor functional outcome. Conclusion: The Helsinki CT score demonstrated the highest standalone discriminative performance; however, all three CT-based scoring systems provided limited incremental prognostic value beyond clinical assessment (age and GCS), supporting their role as complementary rather than independent tools in TBI evaluation. These findings support the use of CT-based scores primarily for early risk stratification and standardized communication in emergency settings, rather than as standalone prognostic tools.
- 22 June 2026
- Published by Springer Nature in BMC Emergency Medicine
- Vol. 26 (1)
Open AccessExternal validation and comparative performance of Marshall, Rotterdam, and Helsinki computed tomography scores in adult traumatic brain injury
Purpose: Computed tomography (CT)-based scoring systems enable standardized quantification of intracranial pathology following traumatic brain injury (TBI). Despite widespread clinical application, external validation studies comparing the Marshall, Rotterdam, and Helsinki CT scores remain limited, particularly in middle-income settings. This study aimed to externally validate these three CT scoring systems and evaluate their incremental prognostic value beyond clinical variables. Methods: This retrospective cohort study included adult patients with traumatic brain injury requiring hospitalization beyond 24 h at a tertiary neurosurgical center between 2022 and 2024. Two neurosurgeons independently scored admission CT scans using the Marshall, Rotterdam, and Helsinki CT scoring systems. The primary outcome was in-hospital mortality, and the secondary outcome was poor functional outcome (Glasgow Outcome Scale 1–3) at hospital discharge. Discriminative performance was assessed using area under the receiver operating characteristic curve (AUC) with DeLong test comparisons. Multivariable logistic regression evaluated incremental prognostic value beyond age and admission Glasgow Coma Scale (GCS). Results: Among 657 patients (mean age 45.9 years, 74.9% male; mild TBI 59.4%, moderate 25.1%, severe 15.5%), in-hospital mortality was 11.0% and poor functional outcome occurred in 23.9%. Among CT-based scores, the Helsinki CT score showed the highest standalone discriminative performance for mortality (AUC 0.793, 95% CI 0.731–0.855), followed by Rotterdam (AUC 0.766, 0.700–0.832) and Marshall (AUC 0.682, 0.625–0.739); Helsinki and Rotterdam both outperformed Marshall. However, when added to a baseline clinical model (age + GCS, AUC 0.876), all CT scores provided minimal to negligible incremental discrimination, with no clinically meaningful improvement in model performance (ΔAUC < 0.005 across all models, all p > 0.20). Similar patterns were observed for poor functional outcome. Conclusion: The Helsinki CT score demonstrated the highest standalone discriminative performance; however, all three CT-based scoring systems provided limited incremental prognostic value beyond clinical assessment (age and GCS), supporting their role as complementary rather than independent tools in TBI evaluation. These findings support the use of CT-based scores primarily for early risk stratification and standardized communication in emergency settings, rather than as standalone prognostic tools.
- 7 February 2026
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 147, 111901
Corrigendum to “Development and temporal validation of an odds ratio-weighted prognostic score (NPH-RKP) for idiopathic normal pressure hydrocephalus shunt surgery: a retrospective cohort study” [J. Clin. Neurosci. 146 (2026) 111883]
- 7 February 2026
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 147, 111901
Corrigendum to “Development and temporal validation of an odds ratio-weighted prognostic score (NPH-RKP) for idiopathic normal pressure hydrocephalus shunt surgery: a retrospective cohort study” [J. Clin. Neurosci. 146 (2026) 111883]